Looks like the FDA has reconsidered their decision to limit emergency contraceptive production to one pharmaceutical company, making it available and more affordable to more people. How this took so long, I do not know, but I'm glad we're here at last.

When the FDA approved of making Plan B available over the counter last July, they also gave the Teva Pharmaceuticals exclusive rights for three years, barring generic brands from producing Plan B because Teva "conducted an additional market study on the product's use by teenagers."


But now the FDA has decided that the grounds for holding off the competition for three years "is too broad." There is, however, a small condition. As NPR reports:

In something of a compromise, the FDA now says the generic versions of the product must still say on their labels that they are intended for "women 17 years of age or older," but they may be sold directly from retail shelves without a requirement to produce proof of age.

I'm not exactly sure what purpose the labeling stipulation serves, but for now I'll just celebrate the expanded access!

Image via AP.